443 related articles for article (PubMed ID: 32067144)
1. Gut Microbiome Modulates Response to Cancer Immunotherapy.
Khan MAW; Ologun G; Arora R; McQuade JL; Wargo JA
Dig Dis Sci; 2020 Mar; 65(3):885-896. PubMed ID: 32067144
[TBL] [Abstract][Full Text] [Related]
2. Exploring the emerging role of the microbiome in cancer immunotherapy.
Fessler J; Matson V; Gajewski TF
J Immunother Cancer; 2019 Apr; 7(1):108. PubMed ID: 30995949
[TBL] [Abstract][Full Text] [Related]
3. The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy.
Gopalakrishnan V; Helmink BA; Spencer CN; Reuben A; Wargo JA
Cancer Cell; 2018 Apr; 33(4):570-580. PubMed ID: 29634945
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiome and cancer immunotherapy.
Li W; Deng Y; Chu Q; Zhang P
Cancer Lett; 2019 Apr; 447():41-47. PubMed ID: 30684593
[TBL] [Abstract][Full Text] [Related]
5. Microbiota Manipulated to Enhance Immunity.
Cancer Discov; 2019 Jul; 9(7):822. PubMed ID: 31072874
[TBL] [Abstract][Full Text] [Related]
6. Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors.
Rezasoltani S; Yadegar A; Asadzadeh Aghdaei H; Reza Zali M
Cancer Med; 2021 Feb; 10(3):1141-1154. PubMed ID: 33369247
[TBL] [Abstract][Full Text] [Related]
7. The Impact of the Fecal Microbiome on Cancer Immunotherapy.
Osman AEG; Luke JJ
BioDrugs; 2019 Feb; 33(1):1-7. PubMed ID: 30604388
[TBL] [Abstract][Full Text] [Related]
8. How gut microbes are joining the fight against cancer.
Guglielmi G
Nature; 2018 May; 557(7706):482-484. PubMed ID: 29795257
[No Abstract] [Full Text] [Related]
9. Gut microbiota and cancer immunotherapy: prognostic and therapeutic implications.
Guven DC; Aktas BY; Simsek C; Aksoy S
Future Oncol; 2020 Mar; 16(9):497-506. PubMed ID: 32100550
[TBL] [Abstract][Full Text] [Related]
10. Contribution of Aging, Obesity, and Microbiota on Tumor Immunotherapy Efficacy and Toxicity.
Baiden-Amissah REM; Tuyaerts S
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31340438
[TBL] [Abstract][Full Text] [Related]
11. The intimate relationship between gut microbiota and cancer immunotherapy.
Elkrief A; Derosa L; Zitvogel L; Kroemer G; Routy B
Gut Microbes; 2019; 10(3):424-428. PubMed ID: 30339501
[TBL] [Abstract][Full Text] [Related]
12. Role of the intestinal microbiome and microbial-derived metabolites in immune checkpoint blockade immunotherapy of cancer.
Hayase E; Jenq RR
Genome Med; 2021 Jun; 13(1):107. PubMed ID: 34162429
[TBL] [Abstract][Full Text] [Related]
13. The microbiome, cancer, and cancer therapy.
Helmink BA; Khan MAW; Hermann A; Gopalakrishnan V; Wargo JA
Nat Med; 2019 Mar; 25(3):377-388. PubMed ID: 30842679
[TBL] [Abstract][Full Text] [Related]
14. Gut microbiome and cancer immunotherapy.
Sun JY; Yin TL; Zhou J; Xu J; Lu XJ
J Cell Physiol; 2020 May; 235(5):4082-4088. PubMed ID: 31663125
[TBL] [Abstract][Full Text] [Related]
15. Interaction between drugs and the gut microbiome.
Weersma RK; Zhernakova A; Fu J
Gut; 2020 Aug; 69(8):1510-1519. PubMed ID: 32409589
[TBL] [Abstract][Full Text] [Related]
16. Immunopathogenesis of Immune Checkpoint Inhibitor-Related Adverse Events: Roles of the Intestinal Microbiome and Th17 Cells.
Anderson R; Theron AJ; Rapoport BL
Front Immunol; 2019; 10():2254. PubMed ID: 31616428
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of immunotherapy, gut microbiota and impact of antibiotic use: are there confounding factors?
Milano G
Cancer Chemother Pharmacol; 2019 Jul; 84(1):223-224. PubMed ID: 30980131
[No Abstract] [Full Text] [Related]
18. Gut microbiome in cancer immunotherapy: Current trends, translational challenges and future possibilities.
Pandey P; Khan F
Biochim Biophys Acta Gen Subj; 2023 Sep; 1867(9):130401. PubMed ID: 37307905
[TBL] [Abstract][Full Text] [Related]
19. Cancer and the Microbiome-Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy.
Matson V; Chervin CS; Gajewski TF
Gastroenterology; 2021 Jan; 160(2):600-613. PubMed ID: 33253684
[TBL] [Abstract][Full Text] [Related]
20. The Microbiome in Immuno-oncology.
Toker J; Arora R; Wargo JA
Adv Exp Med Biol; 2020; 1244():325-334. PubMed ID: 32301026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
